ReviewInvestigative ophthalmology & visual science2025
Recent Advances in Stem Cells of Corneal Epithelia.
Review in Investigative ophthalmology & visual science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Ocular Surface Inflammation as a Driver of Cornea Limbal Stem Cell Deficiency: Mechanisms and Implications.International journal of molecular sciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The cornea, which refracts light toward the retina and acts as a protective barrier for the eye, is critical for our visual system. The corneal epithelium, continuously renewed by corneal epithelial stem cells (CESCs), is required to maintain corneal transparency and thus is critical for vision. Recent experiments in corneal epithelial lineage tracing, live imaging, and single-cell RNA sequencing have deepened our understanding of CESCs and uncovered their unexpected properties. In this review, we focus on recent progress in elucidating these essential properties of CESCs, including their location and how they maintain their populations and their heterogeneity. Additionally, we discuss the limitations of current studies and highlight critical issues that urgently need to be addressed in the field of CESCs. These new insights into CESCs will evolve into game-changing therapeutics for corneal diseases by harnessing CESCs in regenerative medicine.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.